| Literature DB >> 27523073 |
Satoko Miyamoto1, Atsushi Ohkubo1, Hiroshi Seshima1, Takuma Maeda1, Ayako Itagaki1, Naoki Kurashima1, Soichiro Iimori2, Shotaro Naito2, Eisei Sohara2, Tatemitsu Rai2, Shinichi Uchida2, Tomokazu Okado2.
Abstract
While plasma exchange (PE) can eliminate plasma proteins, including all immunoglobulin (Ig) and coagulation factors, selective plasma exchange (SePE) can retain fibrinogen (Fbg). Here, we investigated the removal dynamics of Ig and Fbg in 53 patients with immunological disorders by PE, SePE, and a combination of the two. When the mean processed plasma volume (PPV) was 0.9 plasma volume (PV), the mean percent reductions of Ig and Fbg by PE were both approximately 62%-65%. When the mean PPV was 1.1 PV, the mean percent reductions by SePE were 53.1% for IgG, 30.1% for IgA, 3.6% for IgM, and 19.0% for Fbg, respectively. In the three plasmapheresis sessions performed on alternate days, we classified treatments into three categories: PE group (PE-PE-PE, N = 2), SePE group (SePE-SePE-SePE, N = 14), and PE/SePE group (PE-SePE-SePE, N = 4). The mean percent reductions of IgG, IgA, IgM, and Fbg were 82.0%, 80.4%, 87.3%, and 80.9%, respectively, for the PE group; 76.4%, 57.7%, 43.3%, and 35.9%, respectively, for the PE/SePE group; and 75.4%, 50.6%, 3.2%, and 29.3%, respectively, for the SePE group. Plasmapheresis modalities can be combined according to clinical conditions, for instance, to achieve both the unspecific removal of pathogens by PE and retention of coagulation factors, such as Fbg, by SePE.Entities:
Keywords: Combination therapy; Fibrinogen; Immunoglobulin; Plasma exchange; Selective plasma exchange
Mesh:
Substances:
Year: 2016 PMID: 27523073 DOI: 10.1111/1744-9987.12465
Source DB: PubMed Journal: Ther Apher Dial ISSN: 1744-9979 Impact factor: 1.762